Literature DB >> 25361048

Induction of IFN-α subtypes and their antiviral activity in mumps virus infection.

Maja Markušić1, Maja Šantak, Tanja Košutić-Gulija, Mladen Jergović, Renata Jug, Dubravko Forčić.   

Abstract

Human type I interferons (IFNs) comprise one IFN-β, -ω, -κ, and -ɛ and 12 different IFN-α subtypes, which play an important role in early host antiviral response. Despite their high structural homology and signaling through the same receptor, IFN-α subtypes exhibit different antiviral, antiproliferative, and immunomodulatory activities. Differences in the production of IFN-α subtypes therefore determine the quality of an antiviral response. In this study, we investigated the pattern of IFN-α subtypes induced in infection with different mumps virus (MuV) strains and examined the MuV sensitivity to the action of IFN-α subtypes. We found that all IFN-α subtypes are being expressed in response to MuV infection with a highly similar IFN-α subtype pattern between the virus strains. We assessed an antiviral activity of several IFN-α subtypes: IFN-α1, IFN-α2, IFN-α4, IFN-α6, IFN-α8, IFN-α14, IFN-α17, and IFN-α21. Although they were all effective in suppressing MuV replication, the intensity and pattern of their action varied between MuV strains. Our results indicate that the overall IFN antiviral activity as well as the activity of specific IFN-α subtypes against MuV depend on a virus strain.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25361048      PMCID: PMC4259174          DOI: 10.1089/vim.2014.0028

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  37 in total

1.  Sendai virus defective-interfering genomes and the activation of interferon-beta.

Authors:  Laura Strahle; Dominique Garcin; Daniel Kolakofsky
Journal:  Virology       Date:  2006-05-02       Impact factor: 3.616

Review 2.  Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors.

Authors:  Kenya Honda; Akinori Takaoka; Tadatsugu Taniguchi
Journal:  Immunity       Date:  2006-09       Impact factor: 31.745

Review 3.  Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures.

Authors:  Richard E Randall; Stephen Goodbourn
Journal:  J Gen Virol       Date:  2008-01       Impact factor: 3.891

4.  Differential receptor subunit affinities of type I interferons govern differential signal activation.

Authors:  Eva Jaks; Martynas Gavutis; Gilles Uzé; Jacques Martal; Jacob Piehler
Journal:  J Mol Biol       Date:  2006-11-18       Impact factor: 5.469

5.  IRF-7 is the master regulator of type-I interferon-dependent immune responses.

Authors:  Kenya Honda; Hideyuki Yanai; Hideo Negishi; Masataka Asagiri; Mitsuharu Sato; Tatsuaki Mizutani; Naoya Shimada; Yusuke Ohba; Akinori Takaoka; Nobuaki Yoshida; Tadatsugu Taniguchi
Journal:  Nature       Date:  2005-03-30       Impact factor: 49.962

6.  Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo.

Authors:  Nina Ank; Hans West; Christina Bartholdy; Kristina Eriksson; Allan R Thomsen; Søren R Paludan
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

Review 7.  Mumps.

Authors:  Anders Hviid; Steven Rubin; Kathrin Mühlemann
Journal:  Lancet       Date:  2008-03-15       Impact factor: 79.321

8.  Induction of dendritic cell production of type I and type III interferons by wild-type and vaccine strains of measles virus: role of defective interfering RNAs.

Authors:  Rupak Shivakoti; Martina Siwek; Debra Hauer; Kimberly L W Schultz; Diane E Griffin
Journal:  J Virol       Date:  2013-05-15       Impact factor: 5.103

9.  Type I interferon subtypes produced by human peripheral mononuclear cells from one normal donor stimulated by viral and non-viral inducing factors.

Authors:  Pierre Palmer; Michael G Tovey; Franck Raschilas; Lilia Brassart; Jean-François Meritet; Raphaël Porcher; Pierre Lebon
Journal:  Eur Cytokine Netw       Date:  2007-06-26       Impact factor: 2.737

10.  Differential type I IFN-inducing abilities of wild-type versus vaccine strains of measles virus.

Authors:  Masashi Shingai; Takashi Ebihara; Nasim A Begum; Atsushi Kato; Toshiki Honma; Kenji Matsumoto; Hirohisa Saito; Hisashi Ogura; Misako Matsumoto; Tsukasa Seya
Journal:  J Immunol       Date:  2007-11-01       Impact factor: 5.422

View more
  3 in total

Review 1.  Interferon-α Subtypes As an Adjunct Therapeutic Approach for Human Immunodeficiency Virus Functional Cure.

Authors:  Jeffy George; Joseph J Mattapallil
Journal:  Front Immunol       Date:  2018-02-22       Impact factor: 7.561

Review 2.  Current view on novel vaccine technologies to combat human infectious diseases.

Authors:  Zrinka Matić; Maja Šantak
Journal:  Appl Microbiol Biotechnol       Date:  2021-12-10       Impact factor: 4.813

3.  Impact of Interferon-alpha1b (IFN-α1b) on Antitumor Immune Response: An Interpretation of the Promising Therapeutic Effect of IFN-alpha1b on Melanoma.

Authors:  Yu Liu; Jingjing Ma; Yuqi Yang; Lin Liu; Guannan Zhu; Xiaoxia Wang; Shiyu Wang; Weinan Guo; Qiao Yue; Tao Zhao; Chunying Li; Tianwen Gao; Qiong Shi
Journal:  Med Sci Monit       Date:  2020-03-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.